Algernon Pharmaceuticals Financial Overview
Algernon Pharmaceuticals's market cap is currently $2.12M. The company's EPS TTM is $-0.0142515; its P/E ratio is -1.39; Algernon Pharmaceuticals is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
